Clinical Importance of the Drug interaction Between Statins and CYP3A4 Inhibitors

Dec-10

AUTHORS : Prof Christopher G. Rowan (Details for study: University of Pennsylvania) now works at COHRDATA, INC, San Clemente, CA, US / Institute for Health, Health Care Policy, and Aging Research at Rutgers, 112 Paterson St
New Brunswick, NJ 08901 – Email: crowan@cohrdata.com – Profile: https://pets.rutgers.edu/people/christopher-rowan/ AND http://www.cohrdata.com/about-us

JOURNAL : University of Pennsylvania Repository Website

REFERENCE: Publicly Accessible Penn Dissertation 283

DOI :

Clinical Importance of the Drug interaction Between Statins and CYP3A4 Inhibitors

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study